Publications

Schlaak M, Cimminiello C, Pigozzo J, Lee J, Grabbe S, Rutkowski P, Mackiewicz J, Tsai KK, Ascierto PA, Mandalà M, Carnevale-Schianca F, Haferkamp S, Atkinson V, Hassel JC, Sandhu S, Sharfman W, Dean E, Noor U, Iyer S, Rabbie R, Ribas A. MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 42012456

Cheo FF, Farishta A, Garcia BM, Ai WZ, Ganapathi K, Pincus LB. Cutaneous Manifestation of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma: A Clue to A Gastrointestinal Malignancy. Journal of cutaneous pathology. 2026. PMID: 42011981

Chari A, Costello C, Krishnan A, Patel K, Banerjee R, Berdeja JG, Biran N, Callander N, Costa LJ, Dhakal B, Gasparetto C, Hansen DK, Kumar A, Nooka AK, Pan D, Richard S. Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps Conference. American journal of hematology. 2026. PMID: 42014940

Rathore U, Dugan E, Thornton H, Kumar VE, Dajani R, Burdick RC, Young JM, Steinhart Z, Lao R, Delviks-Frankenberry KA, Choi W, Henriques WS, Echeverria I, Dann E, Dureja I, Pathak N, Arce MM, McKetney J, Umhoefer JM, Parulekar S, Schmidt R, Polacco BJ, Neidleman J, Montano M, Nguyen VQ, Sali A, Levy JA, Tenthorey JL, Cheng Y, Roan NR, Swaney DL, Kaake RM, Dodgson SE, Hiatt J, Pathak VK, Malik HS, Krogan NJ, Marson A. Systematic discovery of pro- and anti-HIV host factors in primary human CD4+ T cells. Cell. 2026. PMID: 42013838

Puthiyedath R, Dhruva A, Kamal Perera P, Kessler CS. Editorial: The increasing relevance of traditional medicine systems for the primary health care sector and general practice: global research perspectives, volume II. Frontiers in medicine. 2026. PMID: 42136858

Llovet JM, Pinyol R, Affo S, Yarchoan M, Gores GJ, Kelley RK, Lowe SW, Sia D, Villanueva A. Hallmarks of liver cancer: Therapeutic implications. Cell. 2026. PMID: 41997132

Moreno-Rodriguez T, Zhang M, Lundberg A, Shrestha R, Sjöström M, Pasam A, Chan J, Devereux L, Foye A, Zhu X, Weinstein AS, Trigos AS, Wyatt AW, Alumkal JJ, Small EJ, Aggarwal R, Dehm SM, Bootsma ML, Zhao SG, Lupien M, Feng FY, Sandhu S, Quigley DA. Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer. Genome biology. 2026. PMID: 41987223

Juric D, Rugo HS, Reising A, Vervier K, Ma C, Ciruelos EM, Loibl S, Singer CF, Sohn J, Campone M, Conte P, Iwata H, Ghaznawi F, Miller M, Taran T, Su F, André F. Genomic Determinants of Response to Alpelisib Plus Fulvestrant in the SOLAR-1 Trial. Annals of oncology : official journal of the European Society for Medical Oncology. 2026. PMID: 41967638

Moradpour M, Moradi Tochayi A, Houshmand S, Nwihim S, Jiang F, Yadav S, Lindsay S, Bergsland EK, Hope TA. Patterns of Progression After Peptide Receptor Radiopharmaceutical Therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2026. PMID: 41956562

Sorror ML, Artz AS, Olin RL, Ramlal R, Giralt SA. Eligibility is not appropriateness: Reframing the role of age in allogeneic transplant decision-making. Blood advances. 2026. PMID: 41954617

Kernick C, Chow L, Alejandro M, Li K, Foisey MG, Yang X, Hilburger C, Lu J, Wu L, McClellan A, Takacsi-Nagy O, Brajenovic R, Theberath NE, Fuentes EC, Lin E, Hartman A, Truong T, Lee JHJ, Workley L, Ha AS, Ji Y, Putnam N, Andronikou N, Fatima N, Dotson M, Wong KA, Burns CH, Engelhard FAS, Stoyanova E, Vukovic M, Adie T, Lim WA, Roybal K, Santostefano K, Almeida R, Allen GM, Shy BR, Roth TL. Ultra-large targeted DNA integrations in primary human cells. bioRxiv : the preprint server for biology. 2026. PMID: 41993426

Nguyen DH, Bruck M, Rosenbluth JM. A Shape Analysis Algorithm Quantifies Spatial Morphology and Context of 2D to 3D Cell Culture for Correlating Novel Phenotypes with Treatment Resistance. bioRxiv : the preprint server for biology. 2026. PMID: 41993544

Bhalgat A, Micin K, Affer M, Ayupe AC, Gomez I, Schatz JH, Stelekati E, Williams S, Komanduri K, Wieder E, Cocco E, Taylor J. CIPHER-seq enables intracellular multimodal profiling of cytokine responses in single immune cells. Scientific Reports. 2026. PMID: 41951681

Bejan CA, Wang M, Venkateswaran S, Bergmann EA, Hiles L, Xu Y, Chandler GS, Brondfield S, Silverstein J, Wright F, de Dios K, Kim DM, Mukherjee E, Krantz MS, Yao L, Johnson DB, Phillips EJ, Balko JM, Mohindra R, Quandt Z. irAE-GPT: leveraging large language models to identify immune-related adverse events in electronic health records and clinical trial datasets. EBioMedicine. 2026. PMID: 41951517

Reig M, Sanduzzi-Zamparelli M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, Díaz A, Llarch N, Iserte G, Mollà M, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal A, Vogel A, Yanagihara TK, Ayuso C, Torres F, Bruix J. Erratum to 'BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update' [J Hepatol (2026) 631-654]. Journal of hepatology. 2026. PMID: 41936510

Brufsky A, Layman RM, Liu X, Li B, McRoy L, Cohen AB, Estevez M, Cottu P, Curigliano G, Rugo HS. Corrigendum to "Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- bone-only metastatic breast cancer" [The Breast 86 (2026) 104744]. Breast (Edinburgh, Scotland). 2026. PMID: 41936467

Sleeper O, Fortino J, Cho NW, Daud AI, Tsai KK, Lee JC, Alvarado M, Maker AV, Liu L, Kim C, Chan JW. Longitudinal tumor-informed ctDNA monitoring for recurrence and treatment response in melanoma. BMC cancer. 2026. PMID: 41928167

Lee G, Haugg F, Bontempi D, He J, Bitterman DS, Pai S, Guthier C, Fitzgerald KJ, Kozono DE, Kann BH, Aerts HJWL, Mak RH. Multimodal Assessment of Biological Age Following Radiation Therapy Among Patients With Early-Stage NSCLC. JAMA network open. 2026. PMID: 41949867

Nikkilä J, Kumar R, Campbell J, Brandsma I, Pemberton HN, Wallberg F, Nagy K, Scheer I, Vertessy BG, Serebrenik AA, Monni V, Harris RS, Pettitt SJ, Ashworth A, Lord CJ. Correction to: Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells. British journal of cancer. 2026. PMID: 41699262

Fann JR, Vanderlan J, Brewer BW, Corbett C, Keller J, Lahijani S, Niazi SK, Riba MB, Andersen B, Atreya CE, Braun I, Breitbart WS, Channa Y, Farabelli J, Fleishman S, Garcia S, Greenberg DB, Handzo RGF, Horyna A, Huang CH, Hutchinson S, Johns S, La Cava S, Leeper H, Martin S, Mukherjee D, Pailler M, Parnes F, Rao V, Rocha-Cadman X, Scher E, Schuster J, Thompson LMA, Usher A, Valentine AD, Montgomery S, Darlow S. NCCN Guidelines® Insights: Distress Management, Version 1.2026. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41956112